Depyrogenated Sterile Empty Vials Market Size is Projected to Jump USD 7,498.2 Mn by 2026

The global Depyrogenated Sterile Empty Vials Market size is anticipated to around USD 7,498.2 million by 2026, this market is anticipated to grow with 4.8% CAGR during the forecast time period. In the Depyrogenated Sterile Empty Vials Market, The regional segmentation includes current and projected demand in North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

In terms of end-use, compounding labs held the major share in 2018 due to the increasing demand for personalized medicines. The presence of stringent regulatory guidelines in major countries like the US for manufacturing and packaging of parenteral products, which needs the sterilization process to ensure the absence of endotoxin, RNase & DNase and other toxic substances. These kinds of regulation by regulatory bodies are supporting the market growth. Additionally, the presence of substantial compounding pharmacists in developed economies is further bolstering the market value. For instance, according to the International Academy of Compounding Pharmacists, approximately 7,500 compounding pharmacies in the U.S. itself are specialized in advanced compounding services, among them 3,000 pharmacies are involved in the compounding of sterile products.

On the basis of material, the glass segment accounted for the dominating share in 2018 owing to the benefits associated with the glass packaging. The depyrogenated sterile empty glass vials offer improved chemical durability and damage resistance which enable biopharmaceutical and pharmaceutical manufacturers to effectively store and deliver critical drug formulations is the primary factor supporting the segment market value. In addition to this, the increasing adoption of glass vials in plant cell culture, chemical and biological reactions, photobiological studies and in sample collection and storage is further accelerating the market growth.

Get Free Report Sample Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1772

Depyrogenated Sterile Empty Vials Market (By Capacity: 2 ml, 5 ml, 10 ml, 20 ml, More than 20 ml; By Material: Glass, Plastic; By End-Use: Compounding Labs, Clinical Labs, Pharmaceutical Manufacturers, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

In 2018, North America held the major share of the global depyrogenated sterile empty vials market. The increasing investment by pharma and biotech companies in R&D activities for the development of innovative packaging is primarily driving the regional market growth. The region is majorly dependent on the US market, which is the prominent segment of the North America region in terms of both volume and value of depyrogenated sterile empty vials market. For instance, the U.S. President promoted a collaboration in 2017, which was intended to enhance the storage and delivery of pharmaceutical formulations. The initiative was conducted and driven by specialty glass marker Corning, Inc. and two pharmaceutical companies namely, Pfizer, Inc. and Merck, Co. The increasing focus towards the technological advancements in healthcare sector packaging by governmental bodies and major players due to increasing focus towards the sterility is additionally propelling the market value. For instance, the EZ-fill Platform developed by Stevanato Group is particularly designed for use in the manufacturing of sterile depyrogenated vials. The platform offers cost reductions, production process improvement, more flexibility, quality improvement and mitigates risks of breakage, as in turn reduces rejection rate.

Some of the leading competitors are Corning Incorporated, Thermo Fisher Scientific, APG Pharma, DWK Life Sciences, VWR International, Nipro PharmaPackaging, Gerresheimer, Merck KGaA, Radpharm Scientific, Stevanato Group, and SCHOTT. Depyrogenated sterile empty vials companies have announced mergers and acquisitions to expand their position in the depyrogenated sterile empty vials industry. Major players are also moving into new regions with advanced technologies and product offerings. The major companies also offer the product with the Certificates of Analysis (COA) and Certificates of Conformance (COC) by lot number.

Related Reports

Some of the key observations regarding depyrogenated sterile empty vials industry include:

Schott AG has collaborated with the SINDAC, a French engineering firm in 2019 in order to expand its portfolio in advance pharmaceutical packaging.
In 2018, SGD Pharma has introduced Clareo range of molded glass vials for injectable solutions and that too with more flat and uniform bottoms. The benefit of flat and uniform bottoms is easy thermal transfer during freeze-drying processes. The new product development is particularly to expand the product portfolio of the company.
The Environmental Protection Agency (EPA) has updated Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine, 5. As result, companies are required to determine the applied definitions according to their offerings.
Cherwell Laboratories has introduced a new Redipor Broth Kit in 2019, which is designed to help with microbiological QA/QC and monitoring applications. The kit comprises of three empty 30 ml sterile injection vials, a 50 ml Tryptic Soy Broth (TSB) injection vial, a 100 ml TSB broth bag and one 10 ml TSB ampoule.

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1772

Market Segmentation

Market By Capacity

2 ml
5 ml
10 ml
20 ml
More than 20 ml

Market By Material

Glass
Plastic

Market By End-Use

Compounding Labs
Clinical Labs
Pharmaceutical Manufacturers
Others (Contract manufacturing organizations, Distributors)

Market By Geography

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Rest of Europe

Asia-Pacific

China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East & Africa

GCC
South Africa
Rest of Middle East & Africa

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

- What is the overall structure of the market?

- What was the historical value and what is the forecasted value of the market?

- What are the key product level trends in the market?

- What are the market level trends in the market?

- Which of the market players are leading and what are their key differential strategies to retain their stronghold?

- Which are the most lucrative regions in the market space?

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1772

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Depyrogenated Sterile Empty Vials
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Depyrogenated Sterile Empty Vials Market By Capacity
1.2.2.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Capacity (2015-2026)
1.2.2.2. Global Depyrogenated Sterile Empty Vials Market Revenue Share By Capacity in 2018
1.2.2.3. 2 ml
1.2.2.4. 5 ml
1.2.2.5. 10 ml
1.2.2.6. 20 ml
1.2.2.7. More than 20 ml
1.2.3. Depyrogenated Sterile Empty Vials Market By Material
1.2.3.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Material (2015-2026)
1.2.3.2. Glass
1.2.3.3. Plastic
1.2.4. Depyrogenated Sterile Empty Vials Market By End-user
1.2.4.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.4.2. Compounding Labs
1.2.4.3. Clinical Labs
1.2.4.4. Pharmaceutical Manufacturers
1.2.4.5. Others (Contract manufacturing organizations, Distributors)
1.2.5. Depyrogenated Sterile Empty Vials Market By Geography
1.2.5.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
1.2.5.3. Europe Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
1.2.5.4. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
1.2.5.5. Latin America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
1.2.5.6. Middle East and Africa (MEA) Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018

CHAPTER 4. DEPYROGENATED STERILE EMPTY VIALS MARKET BY CAPACITY
4.1. Global Depyrogenated Sterile Empty Vials Revenue By Capacity
4.2. 2 ml
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. 5 ml
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. 10 ml
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. 20 ml
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. More than 20 ml
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. DEPYROGENATED STERILE EMPTY VIALS MARKET BY MATERIAL
5.1. Global Depyrogenated Sterile Empty Vials Revenue By Material
5.2. Glass
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Plastic
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. DEPYROGENATED STERILE EMPTY VIALS MARKET BY END-USER
6.1. Global Depyrogenated Sterile Empty Vials Revenue By End-user
6.2. Compounding Labs
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinical Lab
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Pharmaceutical Manufacturers
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others (Contract manufacturing organizations, Distributors)
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
7.1. North America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Depyrogenated Sterile Empty Vials Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
8.1. Europe Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
9.1. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
10.1. Latin America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
11.1. Middle East & Africa Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Corning Incorporated
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Thermo Fisher Scientific
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. APG Pharma
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. DWK Life Sciences
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. VWR International
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Nipro PharmaPackaging
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Gerresheimer
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Merck KGaA
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Radpharm Scientific
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Stevanato Group
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. SCHOTT
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Type Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Type Portfolio
12.12.5. Key Developments
12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Contact Us:

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Follow Us: LinkedIN | Twitter